1401233-89-3

Basic information

• Product Name: 3-chloro-2-methyl-N-(morpholine-2-ylmethyl)benzenesulfonamide
• Synonyms: 3-chloro-2-methyl-N-(morpholine-2-ylmethyl)benzenesulfonamide
• CAS NO: 1401233-89-3
• Molecular Weight: 304.798
• Mol File: 1401233-89-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-chloro-2-methyl-N-(morpholine-2-ylmethyl)benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-2-methyl-N-(morpholine-2-ylmethyl)benzenesulfonamide(1401233-89-3)
• EPA Substance Registry System: 3-chloro-2-methyl-N-(morpholine-2-ylmethyl)benzenesulfonamide(1401233-89-3)

Safety Data

• Hazardous Substances Data: 1401233-89-3(Hazardous Substances Data)

Upstream product

• 1401232-07-2 methyl N-((4-benzylmorpholine-2-yl)methyl)-3-chloro-2-methylbenzenesulfonamide 
• 40987-25-5 N-benzyl-2-chloromethylmorpholine 
• 110859-47-7 (4-benzylmorpholin-2-yl)methanamine 
• 110859-48-8 N-[(4-benzyl-2-morpholinyl)methyl]phthalimide 

Relevant articles and documents

A COMPOUND FOR INHIBITING HUMAN 11-β-HYDROXY STEROID DEHYDROGENASE TYPE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to a novel compound, or a stereoisomer, or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition for human-11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) comprising the same. The invention provides a compound, which has excellent activity and solubility and is more efficiently formulated and delivered, and a pharmaceutical composition for human-11-beta-hydroxysteroid dehydrogenase type 1 comprising the same.